<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<channel rdf:about="http://hdl.handle.net/10468/455">
<title>Pathology - Journal Articles</title>
<link>http://hdl.handle.net/10468/455</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/10468/465"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/469"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/92"/>
<rdf:li rdf:resource="http://hdl.handle.net/10468/464"/>
</rdf:Seq>
</items>
<dc:date>2013-05-23T20:08:10Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/10468/465">
<title>Warfarin prevalence, indications for use and haemorrhagic events</title>
<link>http://hdl.handle.net/10468/465</link>
<description>Warfarin prevalence, indications for use and haemorrhagic events
Ouirke, William; Cahill, Mary R.; Perera, Kanthi; Sargent, Jeremy; Conway, Jane
Warfarin, the standard oral anticoagulant drug used in Ireland, is a widely prescribed medication, particularly in the elderly. A HSE Mid-Western Area wide audit was undertaken over a 12-month period to examine the prevalence and indications for warfarin use and haemorrhagic complications associated with the drug. Every patient receiving warfarin therapy over a 13-week period was included (2564). The age standardised rate varied from 0.09% of 35-39 year olds to 6.1% of 80-84 year olds. Atrial fibrillation was the most common indication (54%) in patients attending the Mid-Western Regional Hospital anticoagulation clinic. The annual cumulative incidence of adverse haemorrhagic events in patients with a recorded INR &gt; or = 5.0 episode was 16.6%. The incidence of major and minor haemorrhagic events per INR &gt; or = 5.0 episode was 1.3% and 15.3% respectively. The most common sites of haemorrhage were genitourinary (39%) and gastrointestinal (27%). No fatal or intracranial haemorrhage relating to episodes of over-anticoagulation were reported during the audit period. The most frequent reason for over-anticoagulation was drug interaction (43%). In 74% of patients, the elevated INR was reversed by omitting or reducing warfarin dose. In 17% of cases, vitamin K was administered. Only 3% of incidents were treated with fresh frozen plasma or prothrombin complex concentrates.Warfarin, the standard oral anticoagulant drug used in Ireland, is a widely prescribed medication, particularly in the elderly. A HSE Mid-Western Area wide audit was undertaken over a 12-month period to examine the prevalence and indications for warfarin use and haemorrhagic complications associated with the drug. Every patient receiving warfarin therapy over a 13-week period was included (2564). The age standardised rate varied from 0.09% of 35-39 year olds to 6.1% of 80-84 year olds. Atrial fibrillation was the most common indication (54%) in patients attending the Mid-Western Regional Hospital anticoagulation clinic. The annual cumulative incidence of adverse haemorrhagic events in patients with a recorded INR &gt; or = 5.0 episode was 16.6%. The incidence of major and minor haemorrhagic events per INR &gt; or = 5.0 episode was 1.3% and 15.3% respectively. The most common sites of haemorrhage were genitourinary (39%) and gastrointestinal (27%). No fatal or intracranial haemorrhage relating to episodes of over-anticoagulation were reported during the audit period. The most frequent reason for over-anticoagulation was drug interaction (43%). In 74% of patients, the elevated INR was reversed by omitting or reducing warfarin dose. In 17% of cases, vitamin K was administered. Only 3% of incidents were treated with fresh frozen plasma or prothrombin complex concentrates.
</description>
<dc:date>2007-03-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/469">
<title>Writing to patients: a randomised controlled trial</title>
<link>http://hdl.handle.net/10468/469</link>
<description>Writing to patients: a randomised controlled trial
O'Reilly, Máire; Cahill, Mary R.; Perry, Ivan J.
It has been suggested that consultants should consider writing directly to patients with a summary of their outpatient consultation. In a controlled trial involving consecutive new referrals to a haematology outpatient clinic, we randomised patients to receive either a personal letter from their consultant summarising their consultation (n = 77) or a brief note thanking them for attending the clinic (n = 73). Patients were assessed for recall of and satisfaction with the consultation by a single independent observer, using standardised methods. At the second visit to outpatients, the patients' median percentage recall of items discussed during the consultation was 67% (IQ range 50-80%) in the intervention group, versus 57% (IQ range 43-76%) in the control group (p = 0.3). Strongly positive views on the personal letter were expressed by patients and referring clinicians. The findings suggest that although personal letters do not substantially improve recall of the clinical encounter, they are feasible, highly valued by patients and acceptable to referring clinicians.
</description>
<dc:date>2006-03-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/92">
<title>Writing to patients: 'putting the patient in the picture'</title>
<link>http://hdl.handle.net/10468/92</link>
<description>Writing to patients: 'putting the patient in the picture'
O'Reilly, Máire; Cahill, Mary R.; Perry, Ivan J.
We have explored consultant, general practitioner and patient attitudes towards the proposal that following an outpatient consultation, consultants should consider communicating directly with patients in the form of a summary letter, with a copy to the referring general practitioner or other professionals as appropriate. We conducted in-depth interviews with a purposive sample of 20 consultants, 16 patients and 12 general practitioners. The consultants and general practitioners were both involved in the care of participating patients. Patients highlighted the likely value of summary letters including, increased knowledge, improvement recall of the clinical encounter, and reassurance. Clinicians were concerned that patients would not understand letters from consultants. Additional concerns included the impact of letter on consultant-general practitioner relationship and medico-legal issues. These findings reflect fundamental differences in expectations about the nature and quality of communications between doctors and their patients.
</description>
<dc:date>2005-02-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/10468/464">
<title>Inflammation, aspirin, and the risk of cardiovascular disease</title>
<link>http://hdl.handle.net/10468/464</link>
<description>Inflammation, aspirin, and the risk of cardiovascular disease
Cahill, Mary R.; Perry, Ivan J.
</description>
<dc:date>1997-08-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
